Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (171-180 of 217) with videos related to

Pageof 22
Sort By:
Science Advances|November 18, 2022
Multifunctional microrobot with real-time visualization and magnetic resonance imaging for chemoembolization therapy of liver cancerGwangjun Go, Ami Yoo, Kim Tien Nguyen, et al.
Therapeutic Advances in Medical Oncology|September 7, 2019
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study GroupChanghoon Yoo, Hyeon-Su Im, Kyu-Pyo Kim, et al.
Clinical and Translational Medicine|July 20, 2022
S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3-mediated programmed death-ligand 1 expression in colorectal cancerHye-Young Min, Jaebeom Cho, Jeong Yeon Sim, et al.
International Journal of Clinical Oncology|June 15, 2026
Erlotinib plus bevacizumab in EGFR-amplified metastatic solid tumors: results from the KOSMOS I, II study of molecular profiling-guided therapy in advanced cancersJiwon Lee, Jongmin Sim, Yun-Gyoo Lee, et al.
Journal of Hepatocellular Carcinoma|December 3, 2025
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter StudyMira Kang, Won Chul Cha, Dong Hyun Sinn, et al.
Oncotarget|June 1, 2017
Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimenChanghoon Yoo, Jihoon Kang, Kyu-Pyo Kim, et al.
Liver Cancer|December 17, 2024
Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database StudyKyu-Pyo Kim, Kang Mo Kim, Baek-Yeol Ryoo, et al.
International Journal of Surgery (London, England)|March 27, 2024
Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancerWoohyung Lee, Minyoung Oh, Jae Seung Kim, et al.
Biomaterials|June 7, 2020
A novel nanoparticle-based theranostic agent targeting LRP-1 enhances the efficacy of neoadjuvant radiotherapy in colorectal cancerKyoung Jin Lee, Eun Jung Ko, Yun-Yong Park, et al.
The Journal of Biological Chemistry|January 31, 2015
Cellular inhibitor of apoptosis protein 1 (cIAP1) stability contributes to YM155 resistance in human gastric cancer cellsSoo-A Jung, Yong-Man Park, Seung-Woo Hong, et al.
Pageof 22

Showing results (171-180 of 217) with videos related to

Sort By:
Pageof 22
Science Advances|November 18, 2022
Multifunctional microrobot with real-time visualization and magnetic resonance imaging for chemoembolization therapy of liver cancerGwangjun Go, Ami Yoo, Kim Tien Nguyen, et al.
Therapeutic Advances in Medical Oncology|September 7, 2019
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study GroupChanghoon Yoo, Hyeon-Su Im, Kyu-Pyo Kim, et al.
Clinical and Translational Medicine|July 20, 2022
S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3-mediated programmed death-ligand 1 expression in colorectal cancerHye-Young Min, Jaebeom Cho, Jeong Yeon Sim, et al.
International Journal of Clinical Oncology|June 15, 2026
Erlotinib plus bevacizumab in EGFR-amplified metastatic solid tumors: results from the KOSMOS I, II study of molecular profiling-guided therapy in advanced cancersJiwon Lee, Jongmin Sim, Yun-Gyoo Lee, et al.
Journal of Hepatocellular Carcinoma|December 3, 2025
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter StudyMira Kang, Won Chul Cha, Dong Hyun Sinn, et al.
Oncotarget|June 1, 2017
Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimenChanghoon Yoo, Jihoon Kang, Kyu-Pyo Kim, et al.
Liver Cancer|December 17, 2024
Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database StudyKyu-Pyo Kim, Kang Mo Kim, Baek-Yeol Ryoo, et al.
International Journal of Surgery (London, England)|March 27, 2024
Metabolic tumor burden as a prognostic indicator after neoadjuvant chemotherapy in pancreatic cancerWoohyung Lee, Minyoung Oh, Jae Seung Kim, et al.
Biomaterials|June 7, 2020
A novel nanoparticle-based theranostic agent targeting LRP-1 enhances the efficacy of neoadjuvant radiotherapy in colorectal cancerKyoung Jin Lee, Eun Jung Ko, Yun-Yong Park, et al.
The Journal of Biological Chemistry|January 31, 2015
Cellular inhibitor of apoptosis protein 1 (cIAP1) stability contributes to YM155 resistance in human gastric cancer cellsSoo-A Jung, Yong-Man Park, Seung-Woo Hong, et al.
Pageof 22